NEW YORK (GenomeWeb) – Biotechnology company Ignyta announced today that it has received an investigational device exemption (IDE) from the US Food and Drug Administration for its RNA-based companion diagnostic Trailblaze Pharos.
Registering provides access to this and other free content.
Already have an account?Login Now.
The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.
In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.
Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.
A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.